Scarica l'app Stockscreener
6.68
2.45%
0.16
Dopo l'orario di chiusura:
6.69
0.01
+0.15%
Precedente Chiudi:
$6.52
Aprire:
$6.55
Volume 24 ore:
50,730
Relative Volume:
0.38
Capitalizzazione di mercato:
$170.05M
Reddito:
-
Utile/perdita netta:
$-22.38M
Rapporto P/E:
-4.7376
EPS:
-1.41
Flusso di cassa netto:
$-15.54M
1 W Prestazione:
+1.83%
1M Prestazione:
-3.19%
6M Prestazione:
+5.20%
1 anno Prestazione:
+8.44%
Intervallo 1D:
$6.45
$6.725
Intervallo di 1 settimana:
$6.32
$6.725
Portata 52W:
$4.44
$11.80
Nuvectis Pharma Inc Stock (NVCT) Company Profile
Nome
Nuvectis Pharma Inc
Settore
Industria
Telefono
360-837-7232
Indirizzo
1 BRIDGE PLAZA, SUITE 275, FORT LEE
Confronta NVCT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NVCT
Nuvectis Pharma Inc
|
6.68 | 165.98M | 0 | -22.38M | -15.54M | -1.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Nuvectis Pharma Inc Stock (NVCT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-02 | Iniziato | Maxim Group | Buy |
| 2025-03-17 | Iniziato | Laidlaw | Buy |
| 2022-07-13 | Iniziato | Ladenburg Thalmann | Buy |
Nuvectis Pharma Inc Borsa (NVCT) Ultime notizie
What earnings revisions data tells us about Nuvectis Pharma Inc.2025 Stock Rankings & Daily Stock Momentum Reports - Newser
Automated trading signals detected on Nuvectis Pharma Inc.Market Risk Summary & Weekly High Potential Stock Alerts - Newser
Custom watchlist performance reports with Nuvectis Pharma Inc.Bear Alert & Weekly High Potential Stock Alerts - Newser
Analyzing net buyer seller activity in Nuvectis Pharma Inc.Weekly Gains Report & Weekly Market Pulse Alerts - Newser
Published on: 2025-09-05 09:33:51 - Newser
Exit strategy if you’re trapped in Nuvectis Pharma Inc.Portfolio Value Report & Stepwise Swing Trade Plans - Newser
Nuvectis Pharma Inc. recovery potential after sell offWeekly Risk Report & Stock Market Timing Techniques - Newser
Nuvectis Pharma Inc. stock trend outlook and recovery pathJuly 2025 Action & AI Enhanced Trading Alerts - Newser
Price action breakdown for Nuvectis Pharma Inc.Market Growth Report & Breakout Confirmation Trade Signals - Newser
Candlestick signals on Nuvectis Pharma Inc. stock today2025 Macro Impact & Free Safe Entry Trade Signal Reports - Newser
Best data tools to analyze Nuvectis Pharma Inc. stockJuly 2025 Patterns & Reliable Momentum Entry Alerts - Newser
Real time alert setup for Nuvectis Pharma Inc. performanceProduct Launch & Short-Term Trading Opportunity Alerts - Newser
Applying big data sentiment scoring on Nuvectis Pharma Inc.2025 Analyst Calls & Detailed Earnings Play Strategies - Newser
Reversal indicators forming on Nuvectis Pharma Inc. stockMarket Activity Report & Safe Capital Allocation Plans - Newser
Nuvectis Pharma to Participate at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire
Nuvectis Pharma shares rise 1.10% intraday after announcing participation in H.C. Wainwright Global Investment Conference. - AInvest
Nuvectis Pharma, Inc. to Participate in H.C. Wainwright Global Investment Conference with On-Demand Presentation and Virtual Meetings - Quiver Quantitative
Clinical-Stage Oncology Biotech Nuvectis Pharma to Showcase Pipeline at Major Investment Conference - Stock Titan
What recovery options are there for Nuvectis Pharma Inc.Bond Market & Weekly Momentum Stock Picks - Newser
Applying sector rotation models to Nuvectis Pharma Inc.2025 Investor Takeaways & Reliable Volume Spike Alerts - Newser
Nuvectis Pharma Inc. stock prediction for this weekTrade Ideas & Verified Entry Point Detection - Newser
Can momentum traders help lift Nuvectis Pharma Inc.July 2025 Selloffs & Safe Capital Growth Tips - Newser
Nuvectis Pharma Inc. stock chart pattern explained2025 Volatility Report & Real-Time Buy Zone Alerts - Newser
Real time scanner hits for Nuvectis Pharma Inc. explained2025 Market WrapUp & Scalable Portfolio Growth Ideas - Newser
Is Nuvectis Pharma Inc. stock ready for a breakoutIPO Watch & Real-Time Chart Pattern Alerts - Newser
How institutional ownership impacts Nuvectis Pharma Inc. stock2025 Risk Factors & Reliable Breakout Forecasts - Newser
Has Nuvectis Pharma Inc. formed a bullish divergence2025 Market Outlook & Verified Momentum Stock Alerts - Newser
How to escape a deep drawdown in Nuvectis Pharma Inc.Recession Risk & Trade Opportunity Analysis - Newser
Will breakout in Nuvectis Pharma Inc. lead to full recoveryJuly 2025 Trade Ideas & Community Verified Trade Alerts - Newser
Earnings visualization tools for Nuvectis Pharma Inc.2025 Trade Ideas & Fast Entry Momentum Trade Alerts - Newser
How high can Nuvectis Pharma Inc. stock goGlobal Markets & AI Enhanced Trading Alerts - Newser
Evaluating Nuvectis Pharma Inc. with trendline analysisWeekly Trend Summary & Community Trade Idea Sharing Platform - Newser
What is Nuvectis Pharma Inc. s 5 year growth outlookWeekly Profit Analysis & Consistent Return Strategy Ideas - خودرو بانک
Volume spikes in Nuvectis Pharma Inc. stock – what they mean2025 Valuation Update & Fast Exit Strategy with Risk Control - Newser
Applying Elliott Wave Theory to Nuvectis Pharma Inc.Chart Signals & High Conviction Buy Zone Picks - Newser
Is Nuvectis Pharma Inc. stock bottoming outMarket Weekly Review & Daily Stock Trend Watchlist - Newser
Is Nuvectis Pharma Inc. trending in predictive chart models2025 Macro Impact & Technical Confirmation Alerts - Newser
What Fibonacci levels say about Nuvectis Pharma Inc. reboundEarnings Risk Report & Fast Gain Stock Tips - Newser
Nuvectis Pharma Inc Azioni (NVCT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):